Erythromelalgia accompanying rosuvastatin-associated myopathy.

about

A generalised sensation of coldness following introduction of rosuvastatin therapy.Erythromelalgia: a cutaneous manifestation of neuropathy?

P2860

Q42941912-44DDF78D-0975-4392-A19D-4089E0838404 Q52325070-24A5EA7C-8476-4DF8-A318-0DF4E30D597D

P2860

Erythromelalgia accompanying rosuvastatin-associated myopathy.

Item

http://www.wikidata.org/entity/Q42727132

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Erythromelalgia accompanying rosuvastatin-associated myopathy.

@en

Erythromelalgia accompanying rosuvastatin-associated myopathy.

@nl

type

Item

label

Erythromelalgia accompanying rosuvastatin-associated myopathy.

@en

Erythromelalgia accompanying rosuvastatin-associated myopathy.

@nl

prefLabel

Erythromelalgia accompanying rosuvastatin-associated myopathy.

@en

Erythromelalgia accompanying rosuvastatin-associated myopathy.

@nl

P1476

Erythromelalgia accompanying rosuvastatin-associated myopathy.

@en

P2093

Nevio Cimolai

http://www.w3.org/2001/XMLSchema#string

Tomas Cimolai

http://www.w3.org/2001/XMLSchema#string

P2860

Erythromelalgia

Rosuvastatin--a highly effective new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor: review of clinical trial data at 10-40 mg doses in dyslipidemic patients.

Erythromelalgia: new theories and new therapies.

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

An overview of the extra-lipid effects of rosuvastatin.

The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases.

Linear IgA bullous dermatosis induced by atorvastatin.

Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients.

Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial.

P304

1-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.3315/JDCR.2009.1026

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51614378

http://www.w3.org/2001/XMLSchema#string

P698

21886718

http://www.w3.org/2001/XMLSchema#string

P932

3157787

http://www.w3.org/2001/XMLSchema#string

Erythromelalgia accompanying rosuvastatin-associated myopathy.

about

P2860

P2860

Erythromelalgia accompanying rosuvastatin-associated myopathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932